Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey

Adverse events are frequent in nontuberculous mycobacteria pulmonary disease treatment, but evidence to support their management is scarce. An expert panel survey on management of adverse events shows consistent opinions on management of hepatoxicity, ocular toxicity, ototoxicity, tinnitus, and gast...

Descripción completa

Detalles Bibliográficos
Autores principales: van Ingen, Jakko, Aliberti, Stefano, Andrejak, Claire, Chalmers, James D, Codecasa, Luigi R, Daley, Charles L, Hasegawa, Naoki, Griffith, David E, Hoefsloot, Wouter, Huitt, Gwen, Jarand, Julie, Jhun, Byung Woo, Loebinger, Michael R, Marras, Theodore K, Morimoto, Kozo, Polverino, Eva, Ringshausen, Felix C, Santin, Miguel, Thomson, Rachel, Wagner, Dirk, Wallace, Richard J, Winthrop, Kevin L, Yim, Jae-Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491833/
https://www.ncbi.nlm.nih.gov/pubmed/32910814
http://dx.doi.org/10.1093/cid/ciaa1361
Descripción
Sumario:Adverse events are frequent in nontuberculous mycobacteria pulmonary disease treatment, but evidence to support their management is scarce. An expert panel survey on management of adverse events shows consistent opinions on management of hepatoxicity, ocular toxicity, ototoxicity, tinnitus, and gastrointestinal upset. These opinions can provide assistance in individual patient management decisions.

Ejemplares similares